Windlas Biotech to raise ₹395-402 crore through public listing, price band fixed at ₹448-460

Advertisement
Windlas Biotech to raise ₹395-402 crore through public listing, price band fixed at ₹448-460
BCCL
  • Windlas Biotech is all set to launch its initial public offering (IPO) in the first week of August.
  • The company provides pharmaceutical development services and large-scale manufacturing services.
  • It is looking to raise ₹402 crore at the upper price band of ₹460.
Windlas Biotech has announced to come up with its initial public offering (IPO) on August 4 with a price band of ₹448-460. The company is looking to raise ₹402 crore on its upper price band.

The company is a pharmaceutical formulations contract development and manufacturing organisation (CDMO). It provides pharmaceutical development services and large-scale manufacturing services.

The offer comprises ₹165 crore of fresh issue and offer for sale upto 51.42 lakh.

Advertisement
Here are the important details to note:
Issue details
Price band₹448 to ₹460
IPO open dateAugust 4
IPO close dateAugust 6
Allotment dateAugust 11
Initiation of refundsAugust 12
Credit of shares to demat accountAugust 13
IPO listing dateAugust 17
Minimum lot30
Source: Company release

Currently, the company has 4 manufacturing facilities located at Dehradun in Uttarakhand.

Proceeds from the IPO will be utilised in purchase of equipments required for capacity expansion of existing facility at Dehradun Plant IV, addition of injectables dosage capability at its existing facility at Dehradun Plant II (₹50 crore), working capital requirements (₹47.5 crore), repayment of debt of ₹20 crore and for general corporate purposes.
Advertisement


ParticularsFY21FY20FY19
Profits₹15.5 crore₹16.2 crore₹63.8 crore
Revenue₹427.6 crore₹328.8 crore₹307.2 crore
Total borrowings₹31.3 crore₹27.4 crore₹29.9 crore

SEE ALSO: It's not just Zomato — From Happiest Minds to CDSL, some of India's hottest stocks are melting too
Hindalco market value crosses 1 lakh crore as share price surges
{{}}